COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
COCRYSTAL PHARMA, INC. (COCP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $8.93 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.93.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $9.07.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $9.39.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $9.57.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $8.93 10-Q · filed 2026-08-13 |
| 2026-03-31 | $9.07 10-Q · filed 2026-05-15 |
| 2025-09-30 | $9.39 10-Q · filed 2025-11-14 |
| 2025-06-30 | $9.57 10-Q · filed 2025-08-14 |
| 2025-03-31 | $11.53 10-Q · filed 2025-05-15 |
| 2024-12-31 | $11.92 10-K · filed 2025-03-31 |
| 2024-09-30 | $12.38 10-Q · filed 2024-11-13 |
| 2024-06-30 | $16.33 10-Q · filed 2024-08-14 |
| 2024-03-31 | $16.70 10-Q · filed 2024-05-13 |
| 2023-12-31 | $17.17 10-K · filed 2024-03-28 |
| 2023-09-30 | $17.68 10-Q · filed 2023-11-13 |
| 2023-06-30 | $24.45 10-Q · filed 2023-08-14 |
| 2023-03-31 | $19.99 10-Q · filed 2023-05-15 |
| 2022-12-31 | $26.53 10-K · filed 2023-03-29 |
| 2022-09-30 | $27.48 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.94 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.98 10-Q · filed 2022-05-11 |
| 2021-12-31 | $3.05 10-K · filed 2022-03-23 |
| 2021-09-30 | $1.99 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.62 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.52 10-Q · filed 2021-05-17 |
| 2020-12-31 | $2.53 10-K · filed 2021-03-17 |
| 2020-09-30 | $2.77 10-Q · filed 2020-11-13 |
| 2020-06-30 | $5.51 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.15 10-Q · filed 2020-05-13 |
| 2019-12-31 | $4.14 10-K · filed 2020-03-27 |
| 2019-09-30 | $4.14 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.70 10-Q · filed 2019-08-09 |
| 2019-03-31 | $5.91 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |